Alzheimer's disease is a degenerative neurological disease that causes a loss of cognitive skills and has no known treatment. Alzheimer's disease (AD) must be detected early, before symptoms appear, in order to be treated effectively. In this study, we used a deep learning approach called a convolutional neural network to classify Alzheimer's disease into three categories using a neuroimaging biomarker called T1w-MRI. Our research is the first to look at the results of three neuroimaging computational approaches in a systematic way (3D subject-level, 3D patch-based and slice-based). To show Alzheimer detection using deep convolutional neural networks, three distinct Slice Based methods are used (Subset selection method, uniform selection method, Interpolation zoom method). For 3D patch-based approaches, we investigated the classification accuracy of distinct non-overlapping patches ranging in size from small to medium to large (from 32, 40, 48, 56, 64, 72, 80, till 88). Our findings revealed that 1) our 3-class classification model performed best, with 98.3 percent accuracy percent (highest accuracy obtained until now as per our best knowledge); 2) The 3D Subject-level approach was the most efficient, followed by 3D-patch-based and then Slice-based approaches, with classification accuracy of 98.26 percent, 97.48 percent, and 95.40 percent, respectively; and 3) The same network had the most accuracy for bigger patches (size 72, 80, 88), followed by medium-sized (size 56, 64) to tiny patches (size 32, 40, 48). Large patches had a classification accuracy of 97.48 percent, while medium patches had a classification accuracy of 96.62 percent, and small patches had an accuracy of 86.49 percent. 4)) Even slice selection and interpolation selection exceeded subset slice selection with three-class classification accuracy of 95.37 percent and 94.57 percent, respectively, compared to 92.57 percent for subset slice selection.